SpringWorks Therapeutics Inc (NASDAQ:SWTX) has a beta value of 0.69 and has seen 1.22 million shares traded in the recent trading session. The company, currently valued at $3.54B, closed the recent trade at $46.96 per share which meant it lost -$0.01 on the day or -0.02%% during that session. The SWTX stock price is -32.03% off its 52-week high price of $62.00 and 39.93% above the 52-week low of $28.21. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.58 million shares traded. The 3-month trading volume is 5.56 million shares.
The consensus among analysts is that SpringWorks Therapeutics Inc (SWTX) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information
Sporting -0.02%% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SWTX stock price touched $46.96 or saw a rise of 0.13%. Year-to-date, SpringWorks Therapeutics Inc shares have moved 29.73%, while the 5-day performance has seen it change 0.20%. Over the past 30 days, the shares of SpringWorks Therapeutics Inc (NASDAQ:SWTX) have changed 1.50%. Short interest in the company has seen 6.24 million shares shorted with days to cover at 1.18.
Wall Street analysts have a consensus price target for the stock at $62.5, which means that the shares’ value could jump 24.86% from the levels at last check today.. The projected low price target is $47.0 while the price target rests at a high of $78.0. In that case, then, we find that the latest price level in today’s session is -66.1% off the targeted high while a plunge would see the stock gain -0.09% from the levels at last check today..
SpringWorks Therapeutics Inc (SWTX) estimates and forecasts
The company’s shares have gained 30.45% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -24.25% over the past 5 years.
SWTX Dividends
SpringWorks Therapeutics Inc is expected to release its next earnings report on 2025-May-09 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s Major holders
Insiders own 1.28% of the company shares, while shares held by institutions stand at 87.36% with a share float percentage of 88.49%. Investors are also buoyed by the number of investors in a company, with SpringWorks Therapeutics Inc having a total of 412.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 11.11 million shares worth more than $418.6 million. As of 2024-06-30, FMR LLC held 14.9922% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 6.54 million shares as of 2024-06-30. The firm’s total holdings are worth over $246.53 million and represent 8.8294% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.04% shares in the company for having 2.29 shares of worth $107.66 million while later fund manager owns 1.78 shares of worth $83.47 million as of Mar 31, 2025 , which makes it owner of about 2.36% of company’s outstanding stock.
